Modifiable Prognostic Factors of Hepatocellular Carcinoma in Patients with Non-Surgical Treatment-Reference-Cited by-同舟云学术

Modifiable Prognostic Factors of Hepatocellular Carcinoma in Patients with Non-Surgical Treatment

Published:2015-12-14 Issue:12 Volume:10 Page:e0144893
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Yeh Jen-Hao,Hung Chao-Hung,Wang Jing-Houng,Chen Chien-Hung,Kee Kwong-Ming,Kuo Chung-Mou,Yen Yi-Hao,Cheng Yu-Fan,Chen Yen-Yang,Hsu Hsuan-Chi,Lu Sheng-Nan

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference34 articles.

1. Outcomes of Liver Transplantation in 490 Patients with Hepatocellular Carcinoma: Validation of a Uniform Staging after Surgical Treatment;J-N Vauthey;Journal of the American College of Surgeons,2007

2. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients;K Okuda;Cancer,1985

3. A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients;Hepatology,1998

4. Prognosis of hepatocellular carcinoma: the BCLC staging classification;JM Llovet;Semin Liver Dis,1999

5. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade;PJ Johnson;J Clin Oncol,2015

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distance Matters: Correlation of Hepatocellular Carcinoma Nodule Distance to Overall Survival;Digestive Diseases;2022-02-16

2. Alterations of telomere length and mtDNA copy number are associated with overall survival in hepatocellular carcinoma patients treated with transarterial chemoembolization;Cancer Chemotherapy and Pharmacology;2016-08-24